Regenerating aged bone marrow via a nitric oxide nanopump.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40593809.
- Also identified by DOI 10.1038/s41467-025-61256-5 and PMC identifier 12219323.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Resident leptin-receptor-expressing (LepR<sup>+</sup>) cells senescence in the aged bone marrow impairs the regenerative capacity of osteo- and other lineages of cells. In this study, a LepR<sup>+</sup> cell-targeting nitric oxide (NO) nanopump with in vivo self-controlled turn-on ability was constructed to rejuvenate the LepR<sup>+</sup> cells in the aged bone marrow. The nanopump co-entrapped hydrophobic chemiluminescence substrate and NO donor into the matrix of amphiphilic polymer through a nanoprecipitation process. The chemiluminescence substrate in the NO nanopump automatically reacts with the accumulated H<sub>2</sub>O<sub>2</sub> in the aged bone marrow and then directly transfers the chemical energy to the NO donor to induce in situ NO release. The NO produced in situ within the aged bone marrow triggered the regeneration of the osteoblastic and the other niches in vivo through activating the glycolysis signaling in the senescent LepR<sup>+</sup> cells. Conclusively, the constructed NO nanopump is a promising tool to counter aging-induced bone marrow disorders.
Medical subject headings
- Nitric Oxide
- Bone Marrow
- Regeneration